HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad M Al-Sanea Selected Research

Mohammad M Al-Sanea Research Topics

Disease

19Neoplasms (Cancer)
12/2023 - 01/2015
4Edema (Dropsy)
09/2023 - 01/2018
4Breast Neoplasms (Breast Cancer)
12/2022 - 01/2018
3Neoplasm Metastasis (Metastasis)
01/2022 - 01/2021
2Inflammation (Inflammations)
09/2023 - 08/2023
2Wounds and Injuries (Trauma)
11/2022 - 04/2022
2Hepatocellular Carcinoma (Hepatoma)
02/2022 - 12/2020
2Leukemia
01/2022 - 01/2015
2Ulcer
01/2022 - 01/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 08/2014
1Rheumatoid Arthritis
09/2023
1Atherosclerosis
09/2023
1Parkinson Disease (Parkinson's Disease)
08/2023
1Dementia (Dementias)
11/2022
1Virus Diseases (Viral Diseases)
01/2022
1Salmonella Infections (Salmonellosis)
11/2021
1Renal Cell Carcinoma (Grawitz Tumor)
10/2021
1Stomach Ulcer (Gastric Ulcer)
04/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
12/2020
1Necrosis
11/2020
1Psoriatic Arthritis
05/2020
1Chromosome Aberrations (Chromosome Abnormalities)
05/2020
1Stomach Neoplasms (Stomach Cancer)
01/2020

Drug/Important Bio-Agent (IBA)

4CarrageenanIBA
09/2023 - 01/2018
3AntioxidantsIBA
03/2023 - 12/2020
3Antineoplastic Agents (Antineoplastics)IBA
05/2022 - 12/2021
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2022 - 01/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 04/2022
2Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2022 - 01/2015
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2021 - 10/2021
2benzofuranIBA
12/2021 - 05/2020
2Carboxylic AcidsIBA
06/2021 - 05/2020
2Protein Isoforms (Isoforms)IBA
06/2021 - 05/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 08/2014
1Sorafenib (BAY 43-9006)FDA Link
12/2023
1LipidsIBA
09/2023
1LigandsIBA
09/2023
1ChitosanIBA
08/2023
1AlginatesIBA
08/2023
1LipopolysaccharidesIBA
08/2023
1oleuropeinIBA
08/2023
1Monoamine Oxidase (MAO)IBA
08/2023
1OximesIBA
08/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2023
1Anti-Allergic Agents (Antiallergic Agents)IBA
03/2023
1Free Radical ScavengersIBA
03/2023
1NanocapsulesIBA
12/2022
1AluminumIBA
11/2022
1Therapeutic UsesIBA
11/2022
1LuteolinIBA
11/2022
1orientinIBA
11/2022
1CollagenIBA
11/2022
1TriterpenesIBA
05/2022
1Transforming Growth Factor-beta Type I ReceptorIBA
04/2022
1EnzymesIBA
02/2022
1NAD (NADH)IBA
02/2022
1Proteins (Proteins, Gene)FDA Link
02/2022
1Oxidoreductases (Dehydrogenase)IBA
02/2022
1quinone (benzoquinone)IBA
02/2022
1trioctyl phosphine oxide (TOPO)IBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1Celecoxib (Celebrex)FDA Link
01/2022
1Benzoates (Benzoate)IBA
01/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022
1Lim KinasesIBA
01/2022
1Dosage Forms (Dosage Form)IBA
11/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021
1Superoxide DismutaseIBA
11/2021
1Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
11/2021
1tivozanibIBA
10/2021
1SulfonamidesIBA
06/2021
1SulfonesIBA
06/2021
1Indomethacin (Indometacin)FDA LinkGeneric
04/2021
1Cimetidine (Biomet)FDA LinkGeneric
04/2021
1KetonesIBA
01/2021
1IsoenzymesIBA
01/2021
1Liposomes (Liposome)IBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
13-acetylpyridineIBA
01/2021
1tetramethylpyrazineIBA
01/2021
1Propidium (Propidium Iodide)IBA
01/2021
1carbonic anhydrase XIIIBA
01/2021
1ChalconesIBA
01/2021
1Complex MixturesIBA
01/2021
1TubulinIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1SpirooxindolesIBA
12/2020
1Caspase 3 (Caspase-3)IBA
11/2020
1Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2020
1AcidsIBA
05/2020
1Carbonic Anhydrase InhibitorsIBA
05/2020
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
05/2020
1apremilastIBA
05/2020
1Aurora KinasesIBA
01/2020
1Mediator ComplexIBA
01/2020

Therapy/Procedure

5Therapeutics
11/2022 - 01/2020
1Chemoprevention
02/2022
1Complementary Therapies (Alternative Medicine)
11/2021